Collaboration · Innovation · Win-Win | KFBIO Successfully Hosts the 2nd Overseas Distributors Conference

Recently, KFBIO successfully hosted its 2nd Overseas Distributors Conference. The two-day event brought together pathology experts, industry scholars, business partners, and distributors from more than 20 countries.

Throughout the conference, participants exchanged ideas on digital pathology, artificial intelligence (AI), smart pathology development, and global market strategies. They also discussed the latest trends shaping the future of pathology.

The conference featured a wide range of topics. These included clinical applications, cutting-edge research, new product launches, regional solutions, and international market experience. Together, these sessions highlighted KFBIO’s latest achievements in building a comprehensive digital pathology ecosystem and expanding its global presence.

---

Integrating Clinical Practice and Technology

Building a Strong Foundation for Smart Pathology

The first day focused on the integration of clinical practice and technological innovation.

During the opening ceremony, KFBIO General Manager Liu Bingxian and Vice President Kevin welcomed distributors and partners from around the world. They emphasized the growing importance of digital pathology in improving diagnostic quality and supporting the long-term development of pathology laboratories.

Following the opening remarks, a series of academic and technical presentations provided valuable insights into the latest developments in pathology.

Precision Neuropathology

The session on Precision Neuropathology explored how morphology and molecular diagnostics can work together. Speakers also discussed their application in diseases such as Alzheimer’s disease and highlighted the value of integrated diagnostic approaches.

Advances in Immunofluorescence

Another presentation focused on Immunofluorescence Applications in Cytopathology.

Experts shared real-world clinical screening experience and demonstrated how immunofluorescence technologies can improve diagnostic efficiency and accuracy.

New Product Launches and R&D Roadmap

Next, Vice President Wang Kivi introduced KFBIO’s latest product portfolio and future research and development plans.

His presentation covered the PRX Series, recent advances in fluorescence imaging, and the company’s long-term technology roadmap. In addition, he shared KFBIO’s vision for future innovation in digital pathology.

The first day of the conference opened with a strong focus on clinical pathology and technological innovation.

In the opening remarks, KFBIO’s General Manager Liu Bingxian and VP Kevin warmly welcomed global partners and emphasized the core role of digital pathology in driving high-quality development in pathology.

Showcasing a Complete Digital Pathology Portfolio

Beyond academic presentations, the conference also highlighted KFBIO’s comprehensive product portfolio.

Visitors explored a wide range of solutions, including:

• Remote consultation systems
• Slide delivery robots
• Desktop storage solutions
• Comprehensive pathology AI solutions
• Slide labelers
• Microtomes

Together, these products form a complete digital pathology workflow, covering every stage from specimen processing to digital diagnosis. As a result, laboratories can improve workflow efficiency, enhance specimen traceability, and support standardized pathology operations.

---

Strengthening the Product Portfolio

Building Integrated Digital Pathology Solutions

The afternoon sessions focused on pathology equipment and integrated system capabilities.

During these sessions, KFBIO introduced a broad portfolio of laboratory solutions designed to improve workflow efficiency and support digital transformation.

The showcased products included:

• Batch barcode scanning systems
• Liquid-based cytology preparation devices and reagents
• Tape-based coverslippers
• Tissue processors

Together, these solutions help laboratories standardize specimen processing, reduce manual operations, and improve overall productivity.

Enhancing Data Management and Image Analysis

In addition to laboratory equipment, KFBIO presented its Digital Slide Management System (DSMS) and the HALO Image Analysis Platform.

These solutions demonstrated how digital pathology can improve data management, image analysis, and laboratory collaboration.

Moreover, the integrated platforms enable laboratories to manage digital slides more efficiently while supporting AI-assisted analysis and long-term data storage.

As a result, pathology departments can streamline daily workflows and make better use of digital pathology data.

Supporting Regional Pathology Networks

Another important highlight was KFBIO’s integrated regional pathology center solution.

The presentation demonstrated practical approaches to building regional and centralized pathology service networks.

By connecting multiple healthcare institutions through one digital platform, these solutions improve resource sharing, strengthen collaboration, and expand access to pathology expertise.

Consequently, regional laboratories can deliver more efficient and standardized diagnostic services.

Expanding International Collaboration

The conference also featured an online presentation by Prof. Junya, President of the Asian Digital Pathology Association.

He introduced the latest developments within the association and shared valuable insights into regional cooperation across Asia.

Furthermore, his presentation highlighted new opportunities for international collaboration and knowledge exchange in digital pathology.

---

A Global Perspective on the Future of Digital Pathology

The second day shifted the focus to emerging technologies and global market development.

Experts discussed how digital pathology continues to reshape modern pathology laboratories around the world.

The thematic sessions covered several key topics, including:

• End-to-end pathology workflow information systems
• Pathology foundation models for precision oncology
• “Four-in-One” smart pathology department construction

Together, these presentations explored practical ways to integrate digital technologies and artificial intelligence into routine pathology practice.

As digital transformation accelerates, these technologies are helping laboratories improve efficiency, standardize workflows, and enhance diagnostic quality.

International Perspectives on Digital Pathology

The international guest sessions provided valuable insights from different healthcare systems.

Dr. Kadhem Alkhenaizi from Bahrain presented the results of a Digital Pathology Survey in the GCC Region.

He discussed the real-world challenges facing pathology laboratories while highlighting new opportunities for digital transformation across Gulf countries.

Meanwhile, Dr. Andrés Mosquera from Colombia shared the current status of digital pathology in Latin America and Europe.

His presentation compared policy environments, clinical needs, and implementation models across different regions. These comparisons provided valuable reference points for future international collaboration.

Finally, Dr. Norman, President of the European Digital Pathology Association, delivered an online presentation on the latest developments in digital pathology across Europe. He also shared his perspectives on future industry trends and international cooperation.

---

Deepening Global Partnerships

Building a Stronger Digital Pathology Ecosystem

The conference concluded with a dedicated roundtable discussion on digital pathology and global market development.

During the session, participants explored a wide range of topics. These included digital pathology products, market expansion strategies, implementation experience, and future industry trends.

Meanwhile, KFBIO’s management team and overseas marketing team met face-to-face with distributors from around the world. Together, they discussed new cooperation models and shared long-term development strategies.

These open discussions strengthened mutual understanding and laid a solid foundation for future collaboration

---

Sharing Global Success Stories

Following the roundtable, KFBIO hosted the Outstanding Distributor Awards and an experience-sharing session.

Distributors from Greece, France, Kazakhstan, Egypt, and several other countries shared successful market practices and valuable local experience.

Moreover, they discussed how KFBIO’s digital pathology solutions have supported business growth and customer success in different regions.

These real-world case studies inspired valuable discussions among global partners. They also strengthened confidence in KFBIO’s long-term international development strategy.

Moving Forward Together

Advancing the Future of Digital Pathology

Through this conference, KFBIO demonstrated its comprehensive strengths across digital pathology equipment, pathology information systems, AI-powered applications, and integrated laboratory solutions.

More importantly, the event further strengthened strategic partnerships with distributors and industry partners worldwide.

As digital pathology continues to transform modern healthcare, international collaboration has become increasingly important. Therefore, KFBIO remains committed to working closely with global partners to accelerate innovation and promote the widespread adoption of digital pathology technologies.

Creating Long-Term Value for Pathology Laboratories

Looking ahead, KFBIO will continue investing in technological innovation while expanding its global collaboration network.

The company will work closely with hospitals, research institutions, distributors, and healthcare partners to support the digital transformation of pathology laboratories.

In addition, KFBIO will continue improving its end-to-end digital pathology solutions, covering laboratory automation, whole-slide imaging, pathology information management, AI-assisted diagnosis, and regional pathology services.

Together, these innovations will help laboratories improve workflow efficiency, enhance diagnostic quality, strengthen specimen traceability, and support precision medicine.

Looking Toward the Next Chapter

Collaboration, innovation, and shared success remain at the heart of KFBIO’s global strategy.

By building an open, collaborative, and sustainable digital pathology ecosystem, KFBIO aims to create greater value for customers and partners around the world.

Together with its global distributors, the company will continue advancing digital pathology, accelerating intelligent laboratory development, and contributing to the future of precision diagnostics.